HGM has informed the Exchange regarding a press release dated August 14, 2025, titled "Q1FY2026 IR and Press Release".
HGM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HGM Limited reported strong Q1 FY26 standalone results with revenue from operations of ₹1,360.90 lakhs, up 146% quarter-on-quarter and 144% year-on-year, driven by AI-enabled healthcare and revenue cycle management (RCM) services. Profit after tax rose to ₹172.86 lakhs (up 31% QoQ, 122% YoY), with EPS at ₹1.37 (up 30% QoQ, 121% YoY) and EBITDA at ₹289.38 lakhs (up 97% QoQ, 113% YoY). The company expanded headcount from ~600 to ~1,300 employees to support growth and remains debt-free with strong liquidity. The Board also approved the proposed sale/transfer of its wholly-owned US subsidiary HOVS LLC and the incorporation of a new Cayman Islands subsidiary named HCI LLC. Statutory auditors Lodha & Co LLP issued an unmodified review opinion on the results.
Sharp top-line and bottom-line growth signals strong business momentum and is likely to be viewed positively by investors. The proposed divestiture of HOVS LLC and creation of a new Cayman subsidiary indicate portfolio restructuring that could reshape the group's future earnings mix and warrants close monitoring.